As a responsible company, we act where the needs are greatest and where we can have maximum impact. Together, with our employees and partners, we help provide better health for all.
Access to healthcare for the underserved
Sleeping Sickness: a spectacular leap forward
Nearly 65 million people are at risk of contracting this parasitic disease, which is transmitted by a bite from an infected tsetse fly. Without early diagnosis and treatment, the parasite invades the central nervous system and the resulting disease is usually fatal. Recognized as a public health problem by the World Health Organization (WHO), the number of cases of sleeping sickness, or Human African Trypanosomiasis (HAT), decreased from 26,950 in 2001 to 1,447 in 2017. Since 2001, Sanofi has contributed to the WHO’s target of eradicating the disease by 2020.
An innovative partnership with the non-profit Drugs for Neglected Diseases initiative (DNDi) has resulted in the development of a new oral treatment called fexinidazole. In order to support international efforts, Sanofi will be donating the drug free of charge.
The Democratic Republic of the Congo (DRC) granted marketing approval for fexinidazole on January 30, 2019.
Improving health through education
Pediatric cancer: giving everyone the same chance of survival
Today, the survival rate of children and adolescents with cancer in low- to middle-income countries is 20%, compared with 80% in developed countries. Since 2006, the Sanofi Espoir Foundation My Child Matters program has been a catalyst for the treatment of children with cancer in developing countries. The program helps strengthen local capabilities by training healthcare professionals. It also produces and distributes information on pediatric cancers to promote early detection.
Since the launch of My Child Matters, 58 projects in 42 countries have led to the training of 25,000 healthcare professionals and the treatment of more than 85,000 children.
Partnerships that deliver innovative solutions for access to healthcare
Access to healthcare for women
Mobilizing for the planet
Climate change is one of the greatest challenges of our age. The WHO estimates that between 2030 and 2050 climate change will cause an estimated 250,000 additional deaths each year. Sanofi has committed to "Planet Mobilization", a policy designed to evaluate and limit direct and indirect impacts of our operations on the environment throughout the life cycle of our products.
The main focuses of our efforts to combat climate change are reducing energy consumption, using low-carbon energy sources, and cutting our greenhouse gas emissions. In support of efforts to keep global climate change on a 2°C trajectory, Sanofi joined the Science Based Targets Initiative in March 2018.
Sanofi is committed to deploying a pollution management plan at every priority production site by 2020 and at every production site by 2025.
A socially responsible company committed to community development
In France, 5.5 million people live in the city's 1,514 priority districts (QPVs), identified by the government. The unemployment rate is two and a half times higher than the national average, regardless of the degree.
Sanofi has decided to join the initiative launched by the French government to promote the economic and social integration of young people from these neighbourhoods. Called PAQTE, this program aims to raise awareness among young people about the company, train them, facilitate their recruitment and promote the economic development of local businesses.